Literature DB >> 33252555

Incidence, Clinical Characteristics, Risk Factors, and Outcomes of Upper Gastrointestinal Bleeding in Patients With COVID-19: Results of the UMC-19-S12.

Rebeca González González1, Javier Jacob2, Òscar Miró3, Pere Llorens4, Sònia Jiménez3, Juan González Del Castillo5, Guillermo Burillo-Putze6, Alfonso Martín1, Francisco J Martín-Sánchez5, Jorge G Lamberechts5, Aitor Alquézar-Arbé7, Leopoldo Higa-Sansone7, Sara Gayoso Martín8, Virginia Carbajosa9, Fahd Beddar Chaib10, Manuel Salido11, María J Marchena González12, Ricardo Calvo López13, Félix González Martínez14, José Pavón Monzo15, Desiré M Velarde Herrera16, Ana P Niembro Valdés17, Eva Quero Motto18, José M Ferreras Amez19, Pascual Piñera-Salmerón20.   

Abstract

OBJECTIVE: The authors investigated the incidence, risk factors, clinical characteristics, and outcomes of upper gastrointestinal bleeding (UGB) in patients with coronavirus disease 2019 (COVID-19), who were attending the emergency department (ED), before hospitalization.
METHODS: We retrospectively reviewed all COVID-19 patients diagnosed with UGB in 62 Spanish EDs (20% of Spanish EDs, case group) during the first 2 months of the COVID-19 outbreak. We formed 2 control groups: COVID-19 patients without UGB (control group A) and non-COVID-19 patients with UGB (control group B). Fifty-three independent variables and 4 outcomes were compared between cases and controls.
RESULTS: We identified 83 UGB in 74,814 patients with COVID-19 who were attending EDs (1.11%, 95% CI=0.88-1.38). This incidence was lower compared with non-COVID-19 patients [2474/1,388,879, 1.78%, 95% confidence interval (CI)=1.71-1.85; odds ratio (OR)=0.62; 95% CI=0.50-0.77]. Clinical characteristics associated with a higher risk of COVID-19 patients presenting with UGB were abdominal pain, vomiting, hematemesis, dyspnea, expectoration, melena, fever, cough, chest pain, and dysgeusia. Compared with non-COVID-19 patients with UGB, COVID-19 patients with UGB more frequently had fever, cough, expectoration, dyspnea, abdominal pain, diarrhea, interstitial lung infiltrates, and ground-glass lung opacities. They underwent fewer endoscopies in the ED (although diagnoses did not differ between cases and control group B) and less endoscopic treatment. After adjustment for age and sex, cases showed a higher in-hospital all-cause mortality than control group B (OR=2.05, 95% CI=1.09-3.86) but not control group A (OR=1.14, 95% CI=0.59-2.19) patients.
CONCLUSIONS: The incidence of UGB in COVID-19 patients attending EDs was lower compared with non-COVID-19 patients. Digestive symptoms predominated over respiratory symptoms, and COVID-19 patients with UGB underwent fewer gastroscopies and endoscopic treatments than the general population with UGB. In-hospital mortality in COVID-19 patients with UGB was increased compared with non-COVID patients with UGB, but not compared with the remaining COVID-19 patients.
Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2022        PMID: 33252555     DOI: 10.1097/MCG.0000000000001465

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  3 in total

1.  Characteristics, risk factors and outcomes of gastrointestinal hemorrhage in COVID-19 patients: A meta-analysis.

Authors:  Jie Chen; Ying Hang
Journal:  Pak J Med Sci       Date:  2021 Sep-Oct       Impact factor: 1.088

2.  Clinical and Endoscopic Outcomes in Coronavirus Disease-2019 Patients With Gastrointestinal Bleeding.

Authors:  Hassan Ashktorab; Tiziano Russo; Gholamreza Oskrochi; Giovanni Latella; Sara Massironi; Martina Luca; Lakshmi G Chirumamilla; Adeyinka O Laiyemo; Hassan Brim
Journal:  Gastro Hep Adv       Date:  2022-03-10

Review 3.  Gastrointestinal Bleeding in COVID-19 Patients: A Rapid Review.

Authors:  Alessandra Negro; Giulia Villa; Stefano Rolandi; Alberto Lucchini; Stefano Bambi
Journal:  Gastroenterol Nurs       Date:  2022-07-13       Impact factor: 1.159

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.